# Assessing the Accuracy of Seismofit® as an Estimate of VO2 Peak in Patients With Hepato-pancreato-biliary, Colorectal, and Gastro-oesophageal Cancer

> **NCT05831488** · — · UNKNOWN · sponsor: **Royal Marsden NHS Foundation Trust** · enrollment: 35 (estimated)

## Conditions studied

- Hepato-Biliary Carcinoma in Situ Nos
- Pancreatic Cancer
- Colorectal Cancer
- Gastric Cancer
- Oesophageal Cancer

## Interventions

- **OTHER:** Non-Interventional

## Key facts

- **NCT ID:** NCT05831488
- **Lead sponsor:** Royal Marsden NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-03-01
- **Primary completion:** 2023-10-01
- **Final completion:** 2024-03-01
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2023-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05831488

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05831488, "Assessing the Accuracy of Seismofit® as an Estimate of VO2 Peak in Patients With Hepato-pancreato-biliary, Colorectal, and Gastro-oesophageal Cancer". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05831488. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*